139 results
Page 3 of 7
S-3ASR
5izuxzhhbfk99lhb0nj
2 Feb 21
Automatic shelf registration
8:11am
8-K
EX-99.1
s7xkfxfqj ghnohj3
11 Jan 21
Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook
7:00am
8-K
3x9 vmydieydg3tq1g5
11 Jan 21
Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook
7:00am
8-K
EX-99.2
4o1u1 3nxn
11 Jan 21
Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook
7:00am
8-K
EX-99.1
0eztbyt
17 Jul 20
Amicus Therapeutics Secures $400 Million Non-Dilutive Debt Financing
7:33am
8-K
EX-99.1
2e70hbvx 5o4
7 May 20
Amicus Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates
7:00am
8-K
EX-99.1
uufdieeub7oeqn4
7 Feb 20
Amicus Therapeutics Announces Presentations and Posters at 16th Annual WORLDSymposiumâ„¢ 2020
7:01am
8-K
EX-99.2
wlrp xmyd5tu2
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
EX-99.1
f77p1proakmcdh2dm
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
h9o90wlvx8fyasypbtjl
13 Jan 20
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
7:00am
8-K
EX-99.1
gyp2tk6xs0lz3i8wk
9 Jan 20
Amicus Therapeutics Announces Preliminary 2019 Galafold Revenue - Exceeding Upper End of Prior Guidance
7:03am
8-K
EX-99.1
h5ls34
7 Jan 20
Amicus Therapeutics Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-GAA for Pompe Disease
7:01am